🔗 Permalink

Inventor profile of:

George Fromm

City:

Austin, Texas

Country:

United States

Published Applications:

Last publication date:

2026-06-11

Top Assignees for applications by George Fromm

The entities that hold a legal rights for patent applications filed by inventor Fromm George:

Shattuck Labs, Inc. 18 Austin, TX United States
Shattuck Labs 1 Austin, TX United States

Recent patent applications by Fromm George

George Fromm from Austin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-11

US20260158108A1

Human necessities

MODIFIED MRNA THERAPEUTICS

#2 | 2026-05-21

US20260139030A1

Chemistry; metallurgy

CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION

#3 | 2025-11-13

US20250345406A1

Human necessities

CHIMERIC PROTEINS IN AUTOIMMUNITY

#4 | 2025-10-16

US20250320268A1

Chemistry; metallurgy

CLINICAL DOSING OF SIRP1A CHIMERIC PROTEIN

#5 | 2025-05-08

US20250145681A1

Chemistry; metallurgy

FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES

#6 | 2025-02-27

US20250066446A1

Chemistry; metallurgy

FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES

#7 | 2024-11-07

US20240368242A1

Chemistry; metallurgy

METHODS OF MAKING AND USING EXTRACELLULAR DOMAIN-BASED CHIMERIC PROTEINS

#8 | 2024-09-12

US20240299492A1

Human necessities

COMBINATION THERAPIES WITH SIRP ALPHA-BASED CHIMERIC PROTEINS

#9 | 2024-08-08

US20240262881A1

Chemistry; metallurgy

FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES

#10 | 2024-07-04

US20240218040A1

Chemistry; metallurgy

Fusion proteins for the treatment of cardiometabolic diseases

#11 | 2024-06-13

US20240190939A1

Chemistry; metallurgy

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

#12 | 2024-05-09

US20240148828A1

Human necessities

GAMMA DELTA T-CELL COSTIMULATION

#13 | 2024-05-02

US20240141014A1

Chemistry; metallurgy

MUTANT PD-1 EXTRACELLULAR DOMAINS

#14 | 2024-04-18

US20240122983A1

Human necessities

FLT3L-BASED CHIMERIC PROTEINS

#15 | 2024-02-29

US20240067698A1

Chemistry; metallurgy

VSIG8-BASED CHIMERIC PROTEINS

#16 | 2024-01-18

US20240016892A1

Human necessities

METHODS OF TREATING CANCER USING TIGIT-AND LIGHT-BASED CHIMERIC PROTEINS

#17 | 2024-01-11

US20240011101A1

Chemistry; metallurgy

METHOD OF DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR THERAPIES

#18 | 2023-12-28

US20230416333A1

Chemistry; metallurgy

HOMODIMERIC AND HETERODIMERIC PROTEINS COMPRISING BUTYROPHILIN

#19 | 2023-12-21

US20230408523A1

Physics

METHODS OF IDENTIFYING GAMMA DELTA T CELL-MODULATING AGENTS

#20 | 2023-07-13

US20230220030A1

Chemistry; metallurgy

HETERODIMERIC PROTEINS AND USES THEREOF

#21 | 2023-02-16

US20230048633A1

Chemistry; metallurgy

TGFBR2-BASED CHIMERIC PROTEINS

#22 | 2023-02-16

US20230045794A1

Chemistry; metallurgy

NK CELL-DIRECTED CHIMERIC PROTEINS

#23 | 2023-01-19

US20230020258A1

Chemistry; metallurgy

Heterodimeric proteins for modulating gamma delta T cells

#24 | 2022-10-06

US20220315637A1

Chemistry; metallurgy

Methods of making and using extracellular domain-based chimeric proteins

#25 | 2022-09-29

US20220306715A1

Chemistry; metallurgy

CHIMERIC PROTEINS IN AUTOIMMUNITY

#26 | 2022-08-18

US20220259281A1

Chemistry; metallurgy

CHIMERIC PROTEIN EXPRESSING T-CELLS

#27 | 2022-07-21

US20220227831A1

Chemistry; metallurgy

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

#28 | 2022-06-16

US20220185863A1

Chemistry; metallurgy

COMBINATION THERAPIES

#29 | 2022-05-12

US20220144909A1

Chemistry; metallurgy

CSF1R-BASED CHIMERIC PROTEINS

#30 | 2022-04-21

US20220119481A1

Chemistry; metallurgy

VSIG8-based chimeric proteins

#31 | 2022-01-27

US20220025000A1

Chemistry; metallurgy

HETERODIMERIC PROTEINS FOR MODULATING GAMMA DELTA T CELLS

#32 | 2021-12-09

US20210379153A1

Human necessities

COMBINATION THERAPIES COMPRISING SIRP ALPHA-BASED CHIMERIC PROTEINS

#33 | 2021-10-21

US20210324041A1

Chemistry; metallurgy

COMBINATION THERAPIES

#34 | 2021-10-07

US20210309744A1

Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING PD-1-BASED CHIMERIC PROTEINS

#35 | 2021-07-15

US20210214409A1

Chemistry; metallurgy

Heterodimeric proteins and uses thereof

#36 | 2021-06-17

US20210179689A1

Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING TIM-3-BASED CHIMERIC PROTEINS

#37 | 2021-02-18

US20210046116A1

Human necessities

FLT3L-based chimeric proteins

#38 | 2020-12-24

US20200399344A1

Chemistry; metallurgy

NK CELL-DIRECTED CHIMERIC PROTEINS

#39 | 2020-12-24

US20200399342A1

Chemistry; metallurgy

TIGIT- and light-based chimeric proteins

#40 | 2020-10-01

US20200308238A1

Chemistry; metallurgy

Heterodimeric proteins for modulating gamma delta T cells

#41 | 2020-09-10

US20200283496A1

Chemistry; metallurgy

TIGIT- and light-based chimeric proteins

#42 | 2020-07-16

US20200222503A1

Human necessities

Methods of making and using extracellular domain-based chimeric proteins

#43 | 2020-07-09

US20200216505A1

Chemistry; metallurgy

Heterodimeric proteins for modulating gamma delta T cells

#44 | 2020-04-23

US20200123214A1

Chemistry; metallurgy

CSF1R-based chimeric proteins

#45 | 2020-03-12

US20200079831A1

Chemistry; metallurgy

Heterodimeric proteins and uses thereof

#46 | 2020-03-05

US20200071380A1

Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING SIRP ALPHA-BASED CHIMERIC PROTEINS

#47 | 2020-03-05

US20200071378A1

Chemistry; metallurgy

VSIG8-based chimeric proteins

#48 | 2020-03-05

US20200069733A1

Human necessities

FLT3L-based chimeric proteins

#49 | 2019-12-19

US20190382466A1

Chemistry; metallurgy

CSF1R-CD40L chimeric proteins

#50 | 2019-12-05

US20190367581A1

Chemistry; metallurgy

VSIG8-based chimeric proteins

#51 | 2019-12-05

US20190367579A1

Chemistry; metallurgy

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

#52 | 2019-06-06

US20190169249A1

Chemistry; metallurgy

CSF1R-based chimeric proteins

InventorID:

2521113 ⎘